[{"Assets_0_Q1_USD":41102800000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":382400000.0,"NetIncomeLossConverted_1_Q1_USD":1456500000.0,"RevenuesConverted_1_Q1_USD":5859800000.0,"StockholdersEquity_0_Q1_USD":3078800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":911700000.0,"StockholdersEquityConverted_0_Q1_USD":3197200000.0,"EarningsPerShareBasic_1_Q1_USD":1.6,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":908200000.0,"EarningsPerShareDiluted_1_Q1_USD":1.6,"Ticker":"LLY","CIK":"59478","name":"ELI LILLY & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20200501"}]